NCT06952660 2026-03-12
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Phase 4 Recruiting
Clinical Trials
7 trialsNCT01953107 2021-05-12
Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Sunnybrook Health Sciences Centre
Phase 4 Completed
NCT03423082 2020-10-28
Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.
University of Pittsburgh
Phase 4 Terminated
NCT01432015 2017-03-28
Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting
Gynecologic Oncology Associates
Phase 4 Completed
NCT01492179 2014-05-28
PoPuLAR
Örebro University, Sweden
Phase 4 Completed
NCT01962272 2013-10-14
The Effect of Nutritional Counseling for Cancer Patients
University of Copenhagen
Phase 4 Completed
NCT00628901 2012-07-11
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
Boston Scientific Corporation
Phase 4 Completed